← Research library

Retinalamin schedules and visual-field testing in advanced glaucoma

Comparison in people · 2022

What was studied
17 adults with advanced primary open-angle glaucoma, 34 eyes. Nine received courses every three months and eight every six months.
Main finding
Retinal photosensitivity did not change significantly in this 17-patient schedule comparison. Both groups received Retinalamin.

Reported findings and study design

Two active schedules compared with automated visual-field testing on different devices and programs.

Population or model 17 adults with advanced primary open-angle glaucoma, 34 eyes. Nine received courses every three months and eight every six months.

Dose, route and schedule

Repeat courses every three or six months. The paper describes intramuscular delivery. The administered mass was not verified from this report.

Protocol source ↗ · Original journal full text, methods and Tables 1–3.

Results · Original journal full text, methods and Tables 1–3.
MeasureResultComparison, timing and statistics
Retinal photosensitivityNo statistically significant change
Mean deviation across testing programs−0.36 dB95% CI −4.27 to 3.54

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • No untreated arm. The 2024 OCT report has the same center, group sizes and schedules. It likely describes the same subgroup.

Related publications may describe some of the same participants or experiments.

Source details

Original journal full text, methods and Tables 1–3.

Sources checked

Citation

Human comparative studyFull text available

D. A. Dorofeev and colleagues. Retinalamin schedules and visual-field testing in advanced glaucoma Russian Open Medical Journal. 2022;11:e0109.

Study source ↗ · DOI 10.15275/rusomj.2022.0109 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards